Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN1729164A details advanced purification for citalopram diol intermediates offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel patent CN113788766B offers safer synthesis route. Reduces toxic reagents. High purity supply chain solution for global pharmaceutical manufacturers.
Patent CN112457293B reveals a high-yield TBTU/DBU method for Lorlatinib, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN1910180A details a safer PTC-catalyzed route for tropane intermediates, offering high purity and scalable manufacturing for CNS drug supply chains.
Patent CN112457293B reveals a high-yield TBTU/DBU method for Lorlatinib. Discover cost-effective manufacturing and supply chain advantages for this critical kinase inhibitor.
Novel enzymatic route for Darunavir intermediate (3R, 3aS, 6aR)-hexahydrofuro[2,3-b]furan-3-ol offering high optical purity and industrial scalability.
Patent CN1662486A reveals a high-yield chlorination method reducing thionyl chloride usage. Ideal for reliable pharmaceutical intermediate supplier seeking cost efficiency.
Novel synthesis route for benzofuran derivatives offers cost reduction and scalable manufacturing for pharmaceutical intermediates supply chains globally.
Advanced flow synthesis for Crizotinib intermediates reduces cost and improves supply chain reliability for pharmaceutical manufacturing partners globally seeking scalable solutions.
Patent CN1213991C reveals a copper-catalyzed route for high-purity sertraline intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel fulvestrant preparation method ensures 99.8% purity without column chromatography. Significant cost reduction and scalable supply chain for pharmaceutical intermediates.
Patent CN1173928C reveals a novel dioxane-based process for Deramciclane intermediates, eliminating toxic DMF and suppressing ketone impurities for superior pharmaceutical manufacturing.
Patent CN104371008B reveals high-purity terlipressin synthesis via fragment condensation, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN1139576C details a novel iridium-catalyzed asymmetric hydrogenation process for producing high-purity dextromethorphan intermediates with enhanced supply chain reliability.
Patent CN106518842A reveals optimized Alectinib route enhancing yield and scalability for pharmaceutical manufacturing supply chains globally.
Patent CN113262822A introduces a robust N-heterocyclic carbene palladium catalyst for efficient adapalene production, offering significant cost reduction in API manufacturing.
Patent CN105906656A reveals flow chemistry route for crizotinib intermediate. Reduces cost and energy significantly. Reliable supplier for pharmaceutical intermediates ensuring high purity.
Patent CN119409702B reveals a safer synthesis route for dipyridamole intermediates. Achieve high purity and supply chain stability with advanced catalytic methods.
Novel synthetic method for Polmacoxib intermediate avoiding cyanide. High purity, scalable process for pharmaceutical supply chains.
Patent CN115850111A details a nickel-catalyzed migration defluorination allylation. This method offers cost reduction in pharmaceutical intermediates manufacturing with high regioselectivity.